S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(-0.03%) $0.926
USD/NOK
(-0.12%) $10.83
USD/GBP
(-0.07%) $0.792
USD/RUB
(-0.09%) $92.49

Realtime updates for Hypera S.A. [HYPMY]

Exchange: OTC Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Last Updated28 Mar 2024 @ 13:11

-0.67% $ 6.70

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 13:11):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands...

Stats
Today's Volume 11 924.00
Average Volume 12 134.00
Market Cap 4.24B
EPS $0.782 ( 2023-09-30 )
Last Dividend $0.0640 ( 2023-07-06 )
Next Dividend $0 ( N/A )
P/E 12.88
ATR14 $0 (0.00%)

Hypera S.A. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hypera S.A. Financials

Annual 2023
Revenue: $7.91B
Gross Profit: $4.85B (61.30 %)
EPS: $2.61
Q4 2023
Revenue: $1.85B
Gross Profit: $1.11B (59.94 %)
EPS: $0.490
Q3 2023
Revenue: $2.14B
Gross Profit: $1.35B (63.31 %)
EPS: $0.790
Q2 2023
Revenue: $2.23B
Gross Profit: $1.41B (63.16 %)
EPS: $0.790

Financial Reports:

No articles found.

Hypera S.A. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.0590
(N/A)
$0.117
(N/A)
$0
(N/A)
$0.0590
(N/A)
$0.0640
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Hypera S.A. Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.85 - Stable (16.92%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0770 2011-05-10
Last Dividend $0.0640 2023-07-06
Next Dividend $0 N/A
Payout Date 2023-09-09
Next Payout Date N/A
# dividends 30 --
Total Paid Out $2.45 --
Avg. Dividend % Per Year 0.00% --
Score 4.23 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 5.85
Div. Directional Score 8.08 --
Next Divdend (Est)
(2024-10-23)
$0.0654 Estimate 12.19 %
Dividend Stability
0.49 Below Average
Dividend Score
4.23
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield

Warning: Undefined variable $stockPricesArray in /home/getagraph/public_html/stock.php on line 1111

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
TLGHY Ex Dividend Junior 2023-05-03 Annually 0 0.00%
KGFHY Ex Dividend Knight 2023-10-12 Annually 0 0.00%
CIWV Ex Dividend Knight 2023-07-20 Quarterly 0 0.00%
RGLXY Ex Dividend Junior 2023-04-27 Annually 0 0.00%
FRRVY Ex Dividend Junior 2023-08-04 Sporadic 0 0.00%
AMBK Ex Dividend Knight 2023-09-14 Bi-Monthly 0 0.00%
UMICY Ex Dividend Knight 2023-08-18 Annually 0 0.00%
MCBI Ex Dividend Junior 2023-08-04 Quarterly 0 0.00%
CODYY Ex Dividend Junior 2023-06-08 Sporadic 0 0.00%
SEBC Ex Dividend Junior 2023-08-30 Quarterly 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2081.5005.848.75[0 - 0.5]
returnOnAssetsTTM0.06031.2007.999.59[0 - 0.3]
returnOnEquityTTM0.1471.5009.4710.00[0.1 - 1]
payoutRatioTTM0.461-1.0005.39-5.39[0 - 1]
currentRatioTTM1.7390.8006.305.04[1 - 3]
quickRatioTTM1.2220.8007.526.02[0.8 - 2.5]
cashRatioTTM0.5561.5008.0210.00[0.2 - 2]
debtRatioTTM0.366-1.5003.90-5.85[0 - 0.6]
interestCoverageTTM2.231.000-0.285-0.285[3 - 30]
operatingCashFlowPerShareTTM3.192.008.9410.00[0 - 30]
freeCashFlowPerShareTTM1.9052.009.0510.00[0 - 20]
debtEquityRatioTTM0.870-1.5006.52-9.78[0 - 2.5]
grossProfitMarginTTM0.6261.0002.902.90[0.2 - 0.8]
operatingProfitMarginTTM0.3341.0005.325.32[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2021.0009.999.99[0.2 - 2]
assetTurnoverTTM0.2900.800-1.402-1.122[0.5 - 2]
Total Score10.32

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM12.901.0008.800[1 - 100]
returnOnEquityTTM0.1472.509.6610.00[0.1 - 1.5]
freeCashFlowPerShareTTM1.9052.009.3610.00[0 - 30]
dividendYielPercentageTTM0.8961.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM3.192.008.9410.00[0 - 30]
payoutRatioTTM0.4611.5005.39-5.39[0 - 1]
pegRatioTTM0.04581.500-3.030[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2551.0006.120[0.1 - 0.5]
Total Score5.85

Hypera S.A.

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Química, Sodium Diclofenac, Hydroxyzine, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. is based in São Paulo, Brazil.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators